| LncRNAs | Disease | Experimental methods | Regulated | ![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Pubmed ID | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LINC01503 | gastric cancer | qPCR etc | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | 32207034 | 2020 |
| LINC01503 | glioma | qPCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30840283 | 2019 |
| LINC01503 | colorectal cancer | qPCR, Luciferase reporter assay, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 30542444 | 2018 |
| LINC01503 | cervical cancer | microarray, qPCR etc. | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 27035672 | 2016 |
| LINC01503 | squamous cell carcinoma | RNA-seq, Microarray, qRT-PCR, Western blot, Luciferase reporter assay, in vitro knockdown, RNAi, RIP | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 29454790 | 2018 |
| LINC01503 | Gastric cancer | qRT-PCR;RIP assay;Luciferase reporter assay; | L | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 33200343 | 2020 |
| LINC01503 | Pancreatic cancer | RACE; | L | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 33415167 | 2020 |
| LINC01503 | Ovarian Carcinoma | Dual-luciferase reporter assay;qRT-PCR;etc. | L | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 34425872 | 2021 |